Nautilus Biotechnology, Inc. Quarterly Depreciation in USD from Q2 2020 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Nautilus Biotechnology, Inc. quarterly/annual Depreciation history and growth rate from Q2 2020 to Q2 2024.
  • Nautilus Biotechnology, Inc. Depreciation for the quarter ending June 30, 2024 was $500K, a 25% increase year-over-year.
  • Nautilus Biotechnology, Inc. Depreciation for the twelve months ending June 30, 2024 was $2.08M, a 46.4% increase year-over-year.
  • Nautilus Biotechnology, Inc. annual Depreciation for 2023 was $1.85M, a 51.9% increase from 2022.
  • Nautilus Biotechnology, Inc. annual Depreciation for 2022 was $1.22M, a 19.4% increase from 2021.
  • Nautilus Biotechnology, Inc. annual Depreciation for 2021 was $1.02M, a 43.5% increase from 2020.
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $2.08M $500K +$100K +25% Apr 1, 2024 Jun 30, 2024 10-Q 2024-07-30
Q1 2024 $1.98M $516K +$131K +34% Jan 1, 2024 Mar 31, 2024 10-Q 2024-04-30
Q4 2023 $1.85M $564K +$228K +67.9% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-28
Q3 2023 $1.62M $500K +$200K +66.7% Jul 1, 2023 Sep 30, 2023 10-Q 2023-10-31
Q2 2023 $1.42M $400K +$100K +33.3% Apr 1, 2023 Jun 30, 2023 10-Q 2024-07-30
Q1 2023 $1.32M $385K +$104K +37% Jan 1, 2023 Mar 31, 2023 10-Q 2024-04-30
Q4 2022 $1.22M $336K +$131K +63.9% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-28
Q3 2022 $1.09M $300K $0 0% Jul 1, 2022 Sep 30, 2022 10-Q 2023-10-31
Q2 2022 $1.09M $300K $0 0% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-02
Q1 2022 $1.09M $281K +$67K +31.3% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-02
Q4 2021 $1.02M $205K Oct 1, 2021 Dec 31, 2021 10-K 2023-02-23
Q3 2021 $300K +$100K +50% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-01
Q2 2021 $300K +$100K +50% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-02
Q1 2021 $214K Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-03
Q3 2020 $200K Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-02
Q2 2020 $200K Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.